Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Chethan, Rajegowda"'
Autor:
Kumar, Lalit, Hussain, Mohammad Mir, Chethan, Rajegowda, Sahoo, Ranjit Kumar, Malik, Prabhat S., Sharma, Om Dutt, Mathew, Anisha, Jha, Ankit, Gupta, Ritu, Sharma, Atul, Biswas, Ahitagni, Kumar, Rakesh, Thulkar, Sanjay, Malik, Soumyaranjan, Dutt, Ashish
Publikováno v:
In Clinical Lymphoma, Myeloma and Leukemia September 2022 22(9):e826-e835
Autor:
Saravanan Thiyagarajan, Pradip K. Majumder, Padhma Radhakrishnan, Manjusha Biswas, Govind Babu, Biplab Tewary, Aditi Chatterjee, Bipinesh Sansar, Ram Shankar Upadhayaya, Aneesha Radhakrishnan, Manoj Rajappa, Jayshree Advani, Chethan Rajegowda, Padmaparna Chaudhuri
Publikováno v:
Cancer Biol Ther
The prognosis of AML is generally poor, with 5-year survival rate of 25%. There has been substantial progress in identification of new therapeutic targets, along with approval of at least three targeted therapies for AML in recent years. Nevertheless
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cd7a504cded02ae13429c350444e1d9
https://europepmc.org/articles/PMC7834080/
https://europepmc.org/articles/PMC7834080/
Autor:
Babu, Govind, Chaudhuri, Padmaparna, Rajappa, Manoj, Biswas, Manjusha, Sansar, Bipinesh, Rajegowda, Chethan, Radhakrishnan, Aneesha, Advani, Jayshree, Tewary, Biplab, Radhakrishnan, Padhma, Thiyagarajan, Saravanan, Chatterjee, Aditi, Upadhayaya, Ram Shankar, Majumder, Pradip K
Publikováno v:
Cancer Biology & Therapy; 2021, Vol. 22 Issue 1, p66-78, 13p